M. David Macfarlane - 05 Jan 2022 Form 4 Insider Report for TITAN PHARMACEUTICALS INC (TTNP)

Role
Director
Signature
/S/ M. David MacFarlane
Issuer symbol
TTNP
Transactions as of
05 Jan 2022
Transactions value $
$0
Form type
4
Date filed
05 Jan 2022, 17:53
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTNP Option to Purchase Common Stock Award $0 +10K $0.00 10K 05 Jan 2022 Common Stock 10K $1.18 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.